Literature DB >> 20004862

Diffusion tensor imaging in arginase deficiency reveals damage to corticospinal tracts.

Michael S Oldham1, John W VanMeter, Kyle F Shattuck, Stephen D Cederbaum, Andrea L Gropman.   

Abstract

Individuals with a proximal urea cycle disorder, such as carbamoyl phosphate synthetase deficiency 1 or ornithine transcarbamylase deficiency, may present with encephalopathy resulting from hyperammonemia. The clinical presentation of arginase deficiency is considerably different, characterized by progressive spasticity involving the lower extremities and usually dementia. Diagnosis may be delayed, and patients are often thought to have cerebral palsy. The true etiology of brain injury in arginase deficiency is unknown, but is not thought to be due to hyperammonemia and brain swelling, the mechanism of injury recognized in ornithine transcarbamylase deficiency. Elevated arginine could augment nitric oxide synthesis, leading to oxidative damage. The hypothesis for the present study was that specific brain vulnerability in arginase deficiency would involve microstructural alterations in corticospinal tracts and that this finding, as measured by diffusion tensor imaging, would differ from age-matched control subjects and those with ornithine transcarbamylase deficiency. Diffusion tensor imaging data were compared for a 17-year-old male patient with arginase deficiency, age-matched normal control subjects, and age-matched individuals with ornithine transcarbamylase deficiency. Significant differences were found in suspected areas of interest, specifically in the corticospinal tracts. This finding confirms the hypothesis that the mechanism of injury in arginase deficiency, although still unknown, is unlikely to be similar to that causing ornithine transcarbamylase deficiency.

Entities:  

Mesh:

Year:  2010        PMID: 20004862      PMCID: PMC3758690          DOI: 10.1016/j.pediatrneurol.2009.07.017

Source DB:  PubMed          Journal:  Pediatr Neurol        ISSN: 0887-8994            Impact factor:   3.372


  13 in total

1.  In vivo visualization of human neural pathways by magnetic resonance imaging.

Authors:  S Mori; W E Kaufmann; G D Pearlson; B J Crain; B Stieltjes; M Solaiyappan; P C van Zijl
Journal:  Ann Neurol       Date:  2000-03       Impact factor: 10.422

2.  Adult-onset arginase deficiency.

Authors:  D M Cowley; F G Bowling; J J McGill; J van Dongen; D Morris
Journal:  J Inherit Metab Dis       Date:  1998-08       Impact factor: 4.982

Review 3.  Urea cycle disorders: diagnosis, pathophysiology, and therapy.

Authors:  S W Brusilow; N E Maestri
Journal:  Adv Pediatr       Date:  1996

4.  Automated image registration: I. General methods and intrasubject, intramodality validation.

Authors:  R P Woods; S T Grafton; C J Holmes; S R Cherry; J C Mazziotta
Journal:  J Comput Assist Tomogr       Date:  1998 Jan-Feb       Impact factor: 1.826

5.  Incidence of inborn errors of metabolism in British Columbia, 1969-1996.

Authors:  D A Applegarth; J R Toone; R B Lowry
Journal:  Pediatrics       Date:  2000-01       Impact factor: 7.124

Review 6.  Argininemia: a treatable genetic cause of progressive spastic diplegia simulating cerebral palsy: case reports and literature review.

Authors:  A N Prasad; J C Breen; M G Ampola; N P Rosman
Journal:  J Child Neurol       Date:  1997-08       Impact factor: 1.987

7.  MR diffusion tensor spectroscopy and imaging.

Authors:  P J Basser; J Mattiello; D LeBihan
Journal:  Biophys J       Date:  1994-01       Impact factor: 4.033

Review 8.  Hyperargininemia due to liver arginase deficiency.

Authors:  Eric A Crombez; Stephen D Cederbaum
Journal:  Mol Genet Metab       Date:  2004-12-19       Impact factor: 4.797

9.  Hyperargininemia with arginase deficiency.

Authors:  S D Cederbaum; K N Shaw; E B Spector; M A Verity; P J Snodgrass; G I Sugarman
Journal:  Pediatr Res       Date:  1979-07       Impact factor: 3.756

Review 10.  Arginases I and II: do their functions overlap?

Authors:  Stephen D Cederbaum; Hong Yu; Wayne W Grody; Rita M Kern; Paul Yoo; Ramaswamy K Iyer
Journal:  Mol Genet Metab       Date:  2004-04       Impact factor: 4.797

View more
  16 in total

Review 1.  Brain imaging in urea cycle disorders.

Authors:  Andrea Gropman
Journal:  Mol Genet Metab       Date:  2010-02-13       Impact factor: 4.797

2.  Hepatic arginase deficiency fosters dysmyelination during postnatal CNS development.

Authors:  Xiao-Bo Liu; Jillian R Haney; Gloria Cantero; Jenna R Lambert; Marcos Otero-Garcia; Brian Truong; Andrea Gropman; Inma Cobos; Stephen D Cederbaum; Gerald S Lipshutz
Journal:  JCI Insight       Date:  2019-09-05

3.  Arginase I deficiency: severe infantile presentation with hyperammonemia: more common than reported?

Authors:  Shailly Jain-Ghai; Sandesh C Sreenath Nagamani; Susan Blaser; Komudi Siriwardena; Annette Feigenbaum
Journal:  Mol Genet Metab       Date:  2011-07-13       Impact factor: 4.797

4.  Long-term survival of the juvenile lethal arginase-deficient mouse with AAV gene therapy.

Authors:  Eun K Lee; Chuhong Hu; Ragini Bhargava; Nora Rozengurt; David Stout; Wayne W Grody; Stephen D Cederbaum; Gerald S Lipshutz
Journal:  Mol Ther       Date:  2012-07-03       Impact factor: 11.454

Review 5.  New frontiers in neuroimaging applications to inborn errors of metabolism.

Authors:  Morgan J Prust; Andrea L Gropman; Natalie Hauser
Journal:  Mol Genet Metab       Date:  2011-06-30       Impact factor: 4.797

Review 6.  The neuropsychiatry of inborn errors of metabolism.

Authors:  Mark Walterfang; Olivier Bonnot; Ramon Mocellin; Dennis Velakoulis
Journal:  J Inherit Metab Dis       Date:  2013-05-23       Impact factor: 4.982

Review 7.  Ammonia toxicity to the brain.

Authors:  Olivier Braissant; Valérie A McLin; Cristina Cudalbu
Journal:  J Inherit Metab Dis       Date:  2012-10-30       Impact factor: 4.982

8.  Lethal phenotype in conditional late-onset arginase 1 deficiency in the mouse.

Authors:  Jennifer Kasten; Chuhong Hu; Ragini Bhargava; Hana Park; Denise Tai; James A Byrne; Bart Marescau; Peter P De Deyn; Lisa Schlichting; Wayne W Grody; Stephen D Cederbaum; Gerald S Lipshutz
Journal:  Mol Genet Metab       Date:  2013-07-06       Impact factor: 4.797

9.  Myocyte-mediated arginase expression controls hyperargininemia but not hyperammonemia in arginase-deficient mice.

Authors:  Chuhong Hu; Jennifer Kasten; Hana Park; Ragini Bhargava; Denise S Tai; Wayne W Grody; Quynh G Nguyen; Stephen D Hauschka; Stephen D Cederbaum; Gerald S Lipshutz
Journal:  Mol Ther       Date:  2014-06-03       Impact factor: 11.454

10.  Recurrent hepatic failure and status epilepticus: an uncommon presentation of hyperargininemia.

Authors:  Husniye Yucel; Çiğdem Seher Kasapkara; Meltem Akcaboy; Erhan Aksoy; Gülseren Evirgen Sahin; Betul Emine Derinkuyu; Saliha Senel; Serdar Ceylaner
Journal:  Metab Brain Dis       Date:  2018-06-30       Impact factor: 3.584

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.